Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan

Br J Haematol. 2003 Sep;122(5):802-5. doi: 10.1046/j.1365-2141.2003.04496.x.

Abstract

Varicella-zoster virus (VZV) infection was studied in 40 adult patients who underwent cord blood transplantation (CBT) from unrelated donors. Twenty-five patients developed VZV reactivation at a median of 5 months after CBT (range 1.7-26 months). The cumulative incidence of VZV reactivation after CBT was 80% at 30 months. Twenty-two patients developed localized herpes zoster. The remaining three patients developed atypical non-localized herpes zoster, which was associated with visceral dissemination in one patient. All the patients responded well to antiviral therapy. Unexpectedly, the absence of grade II-IV acute graft-versus-host disease (GVHD) was associated with a higher rate of VZV reactivation after CBT (100% versus 55%, P=0.01). These results suggest that recovery of VZV-specific immune responses after CBT is delayed even in patients without severe acute GVHD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Acyclovir / therapeutic use
  • Adult
  • Antiviral Agents / therapeutic use
  • Cord Blood Stem Cell Transplantation*
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease
  • Hematologic Diseases / immunology
  • Hematologic Diseases / surgery*
  • Hematologic Diseases / virology
  • Herpes Zoster / drug therapy
  • Herpes Zoster / immunology*
  • Herpesvirus 3, Human / physiology*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Risk Factors
  • Time Factors
  • Transplantation Conditioning
  • Virus Activation*

Substances

  • Antiviral Agents
  • Acyclovir